The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells.
about
Beyond standard therapy: drugs under investigation for the treatment of gastrointestinal stromal tumor.Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.Identification and targeting of an FGFR fusion in a pediatric thalamic "central oligodendroglioma".Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment.
P2860
The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The effects of ponatinib, a mu ...... malignant glioblastoma cells.
@en
type
label
The effects of ponatinib, a mu ...... malignant glioblastoma cells.
@en
prefLabel
The effects of ponatinib, a mu ...... malignant glioblastoma cells.
@en
P2093
P2860
P356
P1476
The effects of ponatinib, a mu ...... malignant glioblastoma cells.
@en
P2093
Guanlin Li
Junxia Zhang
Lingfei Kong
Mengfei Yu
Qiang Zhou
Xiaoqun Gao
Yanfen Wang
Zhihui Fang
P2860
P304
P356
10.2147/OTT.S67556
P407
P577
2014-10-30T00:00:00Z